GE Healthcare Strengthens R&D Efforts in Alzheimer’s Disease

CHALFONT ST GILES, England--(BUSINESS WIRE)--GE Healthcare (Chalfont St. Giles, U.K.; John Dineen, president and CEO), Medical Diagnostics business has entered into research collaboration with Clino Ltd. (Sendai, Miyagi Prefecture; Noriaki Satake, president), a venture by Tohoku University to discover in vivo imaging tracers for tau proteins that accumulate in the brains of Alzheimer’s Disease patients.
MORE ON THIS TOPIC